BU-NOT-SET

CONTACT US
API product list
  • Drug substance
white pills
Fact sheet
Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes
  • Drug substance
Eyes
Insight
The demand for antibiotics and its impact on the pharmaceutical industry since the outbreak of COVID-19
  • Industry trends
Eyes
Insight
Women in leadership
  • Corporate
Eyes
Insight
The state of the oral solid dose development and manufacturing market
  • Drug product
Eyes
Insight
Characterising APIs is Essential for Combo Drug Formulations
  • Drug substance
Eyes
Insight
Outsourcing stability testing
  • Analytical chemistry
Eyes
Insight
Brexit: What’s next for UK pharma?
  • Industry trends
Eyes
Insight
Navigating approval filings choppy international waters
  • Drug substance
Eyes
Insight
Brochure
  • Corporate
Explore Recipharm's Full Service Offering
Insight
  • Drug product
Successful drug development
Insight
  • Manufacturing
How CDMOs can help reduce the risk of counterfeit medicines entering the supply chain
Insight
  • Drug product
Tackling complexity in scale-up
Insight
  • Industry trends
Navigating COVID-19 – the role of CDMOs
Insight
  • Drug product
Best pharmaceutical dosage forms
Insight
  • Analytical chemistry
Taking an innovative approach to analytical chemistry
Insight
  • Analytical chemistry
Recipharm and Oncopeptides collaborate in the development of Melflufen for the treatment of multiple myeloma
Insight
  • Drug product
Excipients for orally disintegrating products